Loss of Rb1 Associated With the Onset of Acquired Resistance to Trastuzumab Deruxtecan in TP53-/HER2-Mutated Non-Small-Cell Lung Cancer: Case Series.

Gupta, Ashish; Jatwani, Karan; Gupta, Kush; Qiu, Jingxin; Dy, Grace K

Gupta, Ashish; Jatwani, Karan; Gupta, Kush; Qiu, Jingxin; Dy, Grace K.

Afiliación

Gupta A; Department of Medicine, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY.
Jatwani K; Department of Medicine, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY.
Gupta K; Department of Medicine, University of Massachusetts Medical School-Baystate, Springfield, MA.
Qiu J; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
Dy GK; Department of Medicine, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY.

JCO Precis Oncol ; 7: e2200476, 2023 02.

Article en En | MEDLINE | ID: mdl-36809053

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; Neoplasias Pulmonares; Humanos; Trastuzumab; Camptotecina; Proteína p53 Supresora de Tumor; Ubiquitina-Proteína Ligasas; Proteínas de Unión a Retinoblastoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google